Ship Healthcare Holdings stock forecast
Ship Healthcare Holdings (SHHPF) Stock Forecast & Price Target
SHHPF Analyst Ratings
SHHPF Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| UBS | $15.95→$18.14 | hold | 10.40%Upside | Reiterated | 02/16/26 | |||
| Kyoichiro Shigemura | Nomura | $24.89 | buy | 51.51%Upside | Reiterated | 02/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| HoldReiterated$15.95→$18.14 | 02/16/26 | 10.40%Upside | |||
| Kyoichiro ShigemuraNomura | BuyReiterated$24.89 | 02/12/26 | 51.51%Upside |
Best Analysts Covering Ship Healthcare Holdings
Copying Kyoichiro Shigemura's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.72% per trade.
Copying Kyoichiro Shigemura's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +17.58% per trade.
Copying Kyoichiro Shigemura's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +16.25% per trade.
SHHPF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, SHHPF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SHHPF average Analyst price target in the past 3 months is ―.
SHHPF Financial Forecast
SHHPF Earnings Forecast
Next quarter’s earnings estimate for SHHPF is $0.23 with a range of $0.23 to $0.23. The previous quarter’s EPS was $0.28. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SHHPF Sales Forecast
Next quarter’s sales forecast for SHHPF is $1.16B with a range of $1.16B to $1.17B. The previous quarter’s sales results were $1.16B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

